141 related articles for article (PubMed ID: 24154923)
1. Long-term survival after excision of a giant esophageal gastrointestinal stromal tumor with imatinib mesylate resistance: report of a case.
Takeno S; Kamei M; Takahashi Y; Ono K; Moroga T; Kawahara K; Yamana I; Maki K; Shiroshita T; Yamashita Y
Surg Today; 2014 Sep; 44(9):1764-7. PubMed ID: 24154923
[TBL] [Abstract][Full Text] [Related]
2. Giant esophageal gastrointestinal stromal tumor: report of a case.
Nakano A; Akutsu Y; Shuto K; Uesato M; Kono T; Hoshino I; Akanuma N; Maruyama T; Isozaki Y; Matsubara H
Surg Today; 2015 Feb; 45(2):247-52. PubMed ID: 24890800
[TBL] [Abstract][Full Text] [Related]
3. Primary gastrointestinal stromal tumor of the liver treated with sequential therapy.
Lin XK; Zhang Q; Yang WL; Shou CH; Liu XS; Sun JY; Yu JR
World J Gastroenterol; 2015 Feb; 21(8):2573-6. PubMed ID: 25741171
[TBL] [Abstract][Full Text] [Related]
4. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
[TBL] [Abstract][Full Text] [Related]
5. The current management of gastrointestinal stromal tumors.
Efron DT; Lillemoe KD
Adv Surg; 2005; 39():193-221. PubMed ID: 16250553
[No Abstract] [Full Text] [Related]
6. Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.
Kanda T; Nishida T; Wada N; Kobayashi O; Yamamoto M; Sawaki A; Boku N; Koseki M; Doi T; Toh Y; Kakeji Y; Sugiyama T; Komatsu Y; Kikuchi S; Ogoshi K; Katai H; Miyachi K; Hirota S; Ohtsu A
Int J Clin Oncol; 2013 Feb; 18(1):38-45. PubMed ID: 22105894
[TBL] [Abstract][Full Text] [Related]
7. Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis.
Speight RA; Nicolle A; Needham SJ; Verrill MW; Bryon J; Panter S
J Clin Oncol; 2013 Jun; 31(16):e245-7. PubMed ID: 23610110
[No Abstract] [Full Text] [Related]
8. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Corless CL; Ballman KV; Antonescu CR; Kolesnikova V; Maki RG; Pisters PW; Blackstein ME; Blanke CD; Demetri GD; Heinrich MC; von Mehren M; Patel S; McCarter MD; Owzar K; DeMatteo RP
J Clin Oncol; 2014 May; 32(15):1563-70. PubMed ID: 24638003
[TBL] [Abstract][Full Text] [Related]
9. High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate.
Okur A; Oguz A; Karadeniz C; Pinarli FG; Ozen O; Ekinci O
Tumori; 2012; 98(2):59e-62e. PubMed ID: 22678007
[TBL] [Abstract][Full Text] [Related]
10. Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.
Hsu CC; Wu CE; Chen JS; Tseng JH; Chiang KC; Liu YY; Tsai CY; Cheng CT; Chen TW; Jan YY; Yeh TS; Chen YY; Yeh CN
Anticancer Res; 2014 Sep; 34(9):5029-36. PubMed ID: 25202087
[TBL] [Abstract][Full Text] [Related]
11. [Gastrointestinal stromal tumors. Actual diagnosis and treatment].
Anton CR; Balan G
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):223-9. PubMed ID: 16607775
[TBL] [Abstract][Full Text] [Related]
12. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.
Yanagawa S; Tanabe K; Suzuki T; Tokumoto N; Arihiro K; Ohdan H
World J Surg Oncol; 2014 Feb; 12():47. PubMed ID: 24575748
[TBL] [Abstract][Full Text] [Related]
13. ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.
Van den Abbeele AD; Gatsonis C; de Vries DJ; Melenevsky Y; Szot-Barnes A; Yap JT; Godwin AK; Rink L; Huang M; Blevins M; Sicks J; Eisenberg B; Siegel BA
J Nucl Med; 2012 Apr; 53(4):567-74. PubMed ID: 22381410
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Dematteo RP; Ballman KV; Antonescu CR; Maki RG; Pisters PW; Demetri GD; Blackstein ME; Blanke CD; von Mehren M; Brennan MF; Patel S; McCarter MD; Polikoff JA; Tan BR; Owzar K;
Lancet; 2009 Mar; 373(9669):1097-104. PubMed ID: 19303137
[TBL] [Abstract][Full Text] [Related]
15. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.
Centonze D; Pulvirenti E; Pulvirenti D'Urso A; Franco S; Cinardi N; Giannone G
Tech Coloproctol; 2013 Oct; 17(5):571-4. PubMed ID: 23361497
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after enucleation of a giant esophageal gastrointestinal stromal tumor.
Mu ZM; Xie YC; Peng XX; Zhang H; Hui G; Wu H; Liu JX; Chen BK; Wu D; Ye YW
World J Gastroenterol; 2014 Oct; 20(37):13632-6. PubMed ID: 25309096
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case.
Nakamura T; Mitomi H; Onozato W; Sato T; Ikeda A; Naito M; Ogura N; Kamata H; Ooki A; Watanabe M
Surg Today; 2012 Nov; 42(11):1096-9. PubMed ID: 22294424
[TBL] [Abstract][Full Text] [Related]
18. Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors.
Bardsley MR; Horváth VJ; Asuzu DT; Lorincz A; Redelman D; Hayashi Y; Popko LN; Young DL; Lomberk GA; Urrutia RA; Farrugia G; Rubin BP; Ordog T
Gastroenterology; 2010 Sep; 139(3):942-52. PubMed ID: 20621681
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors.
Yoo C; Ryu MH; Ryoo BY; Beck MY; Kang YK
Invest New Drugs; 2013 Oct; 31(5):1367-74. PubMed ID: 23591629
[TBL] [Abstract][Full Text] [Related]
20. 'Time is a GIFT in GIST'--the medical and paramedical perspective of a case with metastatic gastrointestinal stromal tumor.
Sevinc A; Camci C
Chemotherapy; 2009; 55(1):11-4. PubMed ID: 18974643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
